Dose-escalation, Safety and Pharmacokinetic Study of Briciclib in Advanced Solid Tumors
Clinical trial NCT02168725 · TERMINATED
Trial details
- NCT number
- NCT02168725
- Sponsor
- Traws Pharma, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2015-12-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.